SCT-B07

N/A

Report date: 2023/01/07 19:50:58

Base Information

Drug NameSCT-B07

Drug Alias NameSCT-B07SCTB07

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Programmed death-ligand 1Anti-TGF-β

TargetsProgrammed death-ligand 1Transforming growth factor beta

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesSinoCelltech Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSinoCelltech Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A